GNRH1 and polycystic ovary syndrome: Similar effects were also noted during the GnRH antagonist protocol (FF AMH; PCOS-Anta = 16.93 ± 18.08 ng/ml vs Control-Anta = 8.51 ± 7.93; P-value = 0.036; Table 3).